Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 09 04:00PM ET
277.63
Dollar change
+5.05
Percentage change
1.85
%
IndexDJIA, NDX, S&P 500 P/E35.55 EPS (ttm)7.81 Insider Own0.24% Shs Outstand537.50M Perf Week-0.17%
Market Cap148.28B Forward P/E13.41 EPS next Y20.70 Insider Trans0.00% Shs Float536.24M Perf Month-13.76%
Income4.23B PEG7.11 EPS next Q5.04 Inst Own78.01% Short Float1.83% Perf Quarter-15.60%
Sales32.32B P/S4.59 EPS this Y4.96% Inst Trans-0.34% Short Ratio3.54 Perf Half Y-8.89%
Book/sh14.00 P/B19.83 EPS next Y5.74% ROA4.66% Short Interest9.81M Perf Year2.33%
Cash/sh16.87 P/C16.46 EPS next 5Y5.00% ROE55.72% 52W Range257.80 - 346.85 Perf YTD-3.61%
Dividend Est.9.11 (3.28%) P/FCF23.60 EPS past 5Y-0.22% ROI6.57% 52W High-19.96% Beta0.54
Dividend TTM9.00 (3.24%) Quick Ratio0.96 Sales past 5Y3.42% Gross Margin60.22% 52W Low7.69% ATR (14)7.88
Dividend Ex-DateNov 18, 2024 Current Ratio1.32 EPS Y/Y TTM-44.30% Oper. Margin20.14% RSI (14)35.75 Volatility2.04% 2.90%
Employees26700 Debt/Eq8.02 Sales Y/Y TTM21.38% Profit Margin13.09% Recom2.26 Target Price329.57
Option/ShortYes / Yes LT Debt/Eq7.55 EPS Q/Q62.38% Payout68.24% Rel Volume1.16 Prev Close272.58
Sales Surprise0.06% EPS Surprise5.79% Sales Q/Q23.11% EarningsOct 30 AMC Avg Volume2.77M Price277.63
SMA20-3.08% SMA50-9.43% SMA200-9.11% Trades Volume3,221,534 Change1.85%
Date Action Analyst Rating Change Price Target Change
Nov-15-24Initiated Wolfe Research Peer Perform
Nov-14-24Initiated Citigroup Neutral $335
Oct-17-24Initiated Bernstein Outperform $380
Oct-14-24Downgrade Truist Buy → Hold $320 → $333
Sep-27-24Initiated Cantor Fitzgerald Overweight $405
Aug-07-24Downgrade Wells Fargo Overweight → Equal Weight $320 → $335
May-03-24Upgrade William Blair Mkt Perform → Outperform
May-03-24Upgrade Barclays Underweight → Equal Weight $230 → $300
Mar-28-24Resumed Raymond James Mkt Perform
Feb-07-24Downgrade Leerink Partners Outperform → Market Perform $324 → $318
Today 01:15PM
04:36AM
Dec-07-24 10:39AM
10:00AM
Dec-06-24 06:07AM
03:14AM Loading…
03:14AM
Dec-05-24 09:00AM
07:28AM
Dec-02-24 04:00PM
08:00AM
07:43AM
Nov-30-24 07:18PM
07:00AM
06:20AM
Nov-29-24 04:30PM
02:06PM Loading…
02:06PM
09:00AM
04:28AM
Nov-27-24 07:10AM
03:57AM
Nov-26-24 06:45PM
05:16PM
04:51PM
04:20PM
03:45PM
02:03PM
01:32PM
01:28PM
01:26PM
01:04PM
01:01PM Loading…
01:01PM
12:03PM
11:56AM
11:31AM
10:44AM
10:17AM
09:54AM
09:33AM
09:16AM
08:54AM
08:36AM
08:32AM
08:31AM
08:11AM
07:05AM
07:00AM
Nov-22-24 04:17PM
09:40AM
08:00AM
Nov-21-24 06:14AM
04:40AM
02:00AM
Nov-20-24 04:00PM
Nov-19-24 03:59PM
Nov-18-24 09:44AM
09:00AM
12:40AM
Nov-16-24 09:00AM
08:45AM
Nov-14-24 04:00PM
01:53PM
10:15AM
09:54AM
08:34AM
Nov-13-24 04:06PM
01:59PM
01:56PM
09:49AM
06:15AM
05:24AM
05:00AM
Nov-12-24 06:26PM
04:43PM
04:38PM
Nov-10-24 07:00AM
Nov-08-24 04:00PM
09:52AM
09:32AM
08:47AM
02:00AM
Nov-05-24 09:00AM
Nov-04-24 06:03PM
07:00AM
Nov-01-24 08:00AM
01:03AM
Oct-31-24 04:15PM
01:48PM
01:39PM
09:28AM
03:21AM
Oct-30-24 08:15PM
05:30PM
05:15PM
04:09PM
04:03PM
04:01PM
Oct-29-24 04:11PM
Oct-26-24 04:30AM
Oct-25-24 04:00PM
09:15AM
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grygiel Nancy A.SVP & CCOMay 03 '24Sale313.092,117662,8029,883May 03 07:48 PM